logo

USCB

USCB Financial·NASDAQ
--
--(--)
--
--(--)
2.55 / 10
Underperform

USCB's financial health is subdued, scoring only 2.5 out of 10. Key weaknesses include low net profit attributable to shareholders ratio and PB-ROE, while gross profit margin and total profit/EBIT show some resilience. The YoY growth in total profit (39.6%) and net assets per share (6.8%) provide limited upside, but overall the fundamentals constrain the stock's performance.

Fundamental(2.55)SentimentTechnical

Analysis Checks(5/10)

Net assets per share (growth rate compared to beginning of year %)
Value6.82
Score3/3
Weight10.33%
1M Return4.47%
Revenue-MV
Value0.16
Score1/3
Weight12.18%
1M Return4.65%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score1/3
Weight6.49%
1M Return3.05%
Gross profit margin (%)
Value36.70
Score3/3
Weight7.40%
1M Return3.43%
Profit-MV
Value-1.92
Score1/3
Weight10.77%
1M Return4.44%
Total profit (YoY growth rate %)
Value39.64
Score3/3
Weight10.48%
1M Return4.68%
PB-ROE
Value1.41
Score1/3
Weight10.77%
1M Return4.93%
Total profit / EBIT (%)
Value100.00
Score3/3
Weight7.41%
1M Return3.43%
Asset-MV
Value-0.50
Score2/3
Weight17.32%
1M Return7.51%
Cash-MV
Value0.14
Score0/3
Weight6.85%
1M Return3.01%
Is USCB fundamentally strong?
  • USCB scores 2.55/10 on fundamentals and holds a Premium valuation at present. Backed by its 11.66% ROE, 33.24% net margin, 11.54 P/E ratio, 1.75 P/B ratio, and 53.85% earnings growth, these metrics solidify its Underperform investment rating.